Well... yes, and no. If they store the results of running the disease screenings, I'm fine with that. I'm uneasy about the insurability ramifications, but hopefully those will soon be less of an issue, one way or the other.
However, if they store a genomic sample (by, for example, storing the blood sample), hypothetically there's nothing to stop them from running the RFLP identifying tests ("DNA fingerprinting") later.
![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png){kind=small}
ninetydegrees
no subject
2010-02-05 21:29 (UTC)However, if they store a genomic sample (by, for example, storing the blood sample), hypothetically there's nothing to stop them from running the RFLP identifying tests ("DNA fingerprinting") later.